Since its establishment in 2001, Create Group has remained committed to advancing human healthcare through pioneering medical innovations. Our products and investments span multiple medical domains including breath diagnostics solutions, AI-powered diagnostic platforms, non-invasive early screening technologies for diabetes and innovative multi-omics precision diagnostic solutions for diabetes and coronary heart disease, alongside targeted therapeutic development projects.

As an innovation-driven enterprise with over two decades of dedication to the health industry, we have established a comprehensive industry chain ecosystem integrating investment, R&D, production, sales and integrated services. Faithfully pursuing our corporate mission of "Safeguarding Human Health through Technological Innovation", we upholds "Innovation Knows No Bounds" as our cultural ethos. Guided by scientific advancement, we continuously invest in R&D resources, pursue exceptional quality, and aspire to become a guardian of human health.